From a cellular laboratory viewpoint, Relafen 750 (Naproxen ) presents a compelling case. Its mechanism of action primarily involves inhibiting cyclooxygenase proteins, specifically COX-1 and COX-2, thereby reducing prostaglandin production . This results in decreased pain and temperature . The compound's relatively long persistence and specific lo